Home
About
FAQ
History (25)
Implementation of a Novel Clinic/Community Partnership Addressing Food Insecurity Among Adults With HIV in the Southern United States: A Program Brief.
Gaps in sexually transmitted infection screening among youth living with HIV in Alabama.
Reduction in high rates of antibiotic-nonsusceptible invasive pneumococcal disease in tennessee after introduction of the pneumococcal conjugate vaccine.
The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).
Transforming growth factor beta as a therapeutic target in systemic sclerosis.
See All 25 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Transforming growth factor beta as a therapeutic target in systemic sclerosis.
Varga J, Pasche B. Transforming growth factor beta as a therapeutic target in systemic sclerosis. Nat Rev Rheumatol. 2009 Apr; 5(4):200-6.
View in:
PubMed
subject areas
Animals
Humans
Ligands
Scleroderma, Systemic
Signal Transduction
Transforming Growth Factor beta